Table 1.
Pseudonym | Gender | Age (years) | Region of origin | BBV test intervention response |
Ryan | Male | 18–29 | North America | BBV test offer declined |
Sofiya | Female | 30–49 | East Europe | BBV test offer not recalled, assumed not tested |
Carlotta | Female | 18–29 | West Europe (excluding the UK) | BBV test offer accepted |
Malcom | Male | 30–49 | UK | BBV test offer not recalled, assumed not tested |
Karen | Female | (30–49*) | UK | BBV test offer accepted |
Ramisa | Female | (30–49*) | South Asia | BBV test offer accepted |
Phil | Male | 30–49 | UK | BBV test offer accepted |
Ehsan | Male | (50+*) | Middle East | BBV test offer not recalled, assumed not tested |
Sten | Male | 30–49 | West Europe | BBV test offer not recalled, assumed not tested |
Dennis | Male | 50+ | UK | BBV test offer accepted |
Hana | Female | 18–29 | South Europe | BBV test offer not recalled, assumed not tested |
Julia | Female | (18–29*) | West Europe | BBV test offer not recalled, assumed not tested |
Matas | Male | 30–49 | East Europe | BBV test offer not recalled, assumed not tested |
Dan | Male | 30–49 | UK | BBV test offer accepted |
Imogen | Female | 50+ | UK | BBV test offer accepted |
Ishani | Female | 30–49 | UK | BBV test offer accepted |
Lena | Female | 18–29 | East Europe | BBV test offer accepted |
Khaled | Male | (30–49*) | Middle East | BBV test offer not recalled, assumed not tested |
*A number of patient interviews were interrupted due to patient care pathways. In cases where interviews were not able to be resumed (eg, where patients were transferred/discharged), patient information has insofar as is possible been extracted from interview data. Where patient ages were not available, an age-range estimate has been given based on biographical information given by patients during the interview.